Numan raises $60M to scale AI-powered preventive health services
Numan, a UK-based digital health company, has secured $60 million in new funding to expand its consumer-first preventive care platform, with a focus on obesity, hormonal health, and international growth.
The investment includes $30 million in equity—led by Big Pi Ventures with participation from Endeavor Catalyst, White Star Capital, and Novator—and $27 million in growth capital from HSBC Innovation Banking.
The new funding will support Numan’s continued expansion across Europe, the development of AI-driven coaching tools, and the launch of new services in women’s health.
Numan’s platform integrates diagnostics, prescription therapies such as GLP-1s, behavioral support, and remote clinical monitoring, offering a vertically integrated approach to preventive care.
Numan at Frontiers Health
Following his participation in the 2024 edition, Numan’s CEO and founder, Sokratis Papafloratos, will return to the Frontiers Health stage for our 10th anniversary global conference.
At last year’s event, he joined moderator Marc Sluijs on the plenary stage for the session "Consumers Rule", highlighting how direct-to-consumer models are enabling sustainable scale and measurable impact in digital health.
Source: www.numan.com
Join us and our global community of health innovators in Berlin on November 11-12, 2025.